Basal and Bolus Insulin Dose Changes after Switching Basal Insulin to Insulin Degludec in Patients with Type 1 Diabetes Mellitus: A Pilot Study.
Yoshiyuki HamamotoSachiko HonjoKanta FujimotoShinsuke TokumotoHiroki IkedaYoshiharu WadaHiroyuki KoshiyamaPublished in: Clinical drug investigation (2018)
DEG improved glycemic control when switched from once-daily BI and maintained glycemic control when switched from twice-daily BI without increasing hypoglycemia.